Cerus Corporation (CERS) Stock Analysis

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

• Price: $2.60
• Market Cap: $464.85M
• EPS: $-0.08
• 52-Week High: $2.96
• 52-Week Low: $1.12

Market Sentiment

Cerus Corporation currently has a Neutral sentiment score of 0.13.

About Cerus Corporation

Cerus Corporation (CERS) is a pioneering biomedical products company focused on improving blood safety through its groundbreaking INTERCEPT Blood System, designed to inactivate pathogens in blood components. Headquartered in Concord, California, Cerus employs state-of-the-art technology to meet the critical demands of transfusion medicine, ensuring enhanced patient safety. With a robust and expanding portfolio, the company is strategically positioned to capitalize on the global need for safe ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Cerus Corporation and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does CERS pay dividends?

Cerus Corporation (CERS) does not currently pay a regular dividend.

What is CERS's market cap?

Cerus Corporation (CERS) has a market capitalization of $464.85M with a current stock price of $2.60.